India, Oct. 27 -- This Penny Pharma Stock, engaged in manufacturing and marketing pharmaceutical products, including beta-lactam dry powder injections, tablets, capsules, and oral rehydration solutions for domestic and international markets, hit a 5 percent upper circuit after receving an order worth Rs. 30 cr from JD Healthcare.

With a market capitalization of Rs. 43.22 crores, the shares of JFL Life Sciences Limited hit a 5 percent upper circuit of Rs. 13.10 per share on Monday, up from its previous closing price of Rs. 12.50 per share.

Reason Behind the Surge JFL Life Sciences Limited has received a new order from JD Healthcare. The order involves supplying Merilyzer Quantilyte Machines, which are pharmaceutical and healthcare instru...